KRAS and lung carcinoma: Considering a previous report that increased SIRT1 expression protects from KRAS-driven lung carcinogenesis [16], we further investigated RAS-dependency in the correlation between SIRT1 expression and survival rates of patients with pancreatic, colorectal, and lung cancers, which frequently carry KRAS mutation(s), particularly on glycine 12 (Figure 1D).